Carol Miceli | Investor Relations |
Jay Luly | President and Chief Executive Officer |
Paul Mellett | Chief Financial Officer |
Brian Abrahams | RBC Capital Markets |
Yasmeen Rahimi | ROTH Capital Partners |
Liisa Bayko | JMP Securities |
Eric Joseph | JPMorgan |
Jay Olson | Oppenheimer |
Good afternoon. My name is Deidra and I will be your conference operator today. At this time, I would like to welcome everyone to the Enanta Pharmaceuticals Fourth Quarter Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session.